Tag: TCT 2018

Orsiro may be the new benchmark for comparison in drug-eluting stent...

At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 September, San Diego, USA), David Kandzari (Piedmont Heart Institute, Atlanta, USA) presented the two-year results...

The resurgence of renal denervation

More than ever before, arterial hypertension represents one of the greatest health threats and challenges for both patients and treating physicians. With the new...

Pulmonary artery denervation: A novel approach to managing pulmonary hypertension

According to the results of PADN-5, pulmonary artery denervation (PADN) is associated with significant improvements in haemodynamic and clinical outcomes in patients with post-capillary...

TCT 2018: Multivessel NIRS is feasible, safe and can predict future...

Ron Waksman The Lipid Rich Plaque (LRP) study indicates that cardiac patients with a high lipid core plaque burden index (LBCI), identified with...

TCT 2018: Sham-controlled trial indicates indirect annuloplasty reduces mitral regurgitation

REDUCE-FMR indicates that indirect annuloplasty with the Carillon device (Cardiac Dimensions) is associated with a significant reduction in mitral regurgitation in patients with secondary...

TCT 2018: Durable tricuspid regurgitation reduction with MitraClip

Data from the TriValve Registry—an international multicentre, retrospective, multidevice, registry evaluating interventional tricuspid repair—indicates that interventional edge-to-edge repair (MitraClip, Abbott) to manage patients with...

TCT 2018: Severe prosthesis-patient mismatch linked to increased mortality at one...

The largest study to date of prosthesis-patient mismatch following transcatheter aortic valve implantation (TAVI) shows that severe mismatch is associated with a significantly higher...

TCT 2018: IVUS-guided PCI reduces target vessel failure in all-comers population

Jun-jie Zhang (Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China) and others report in the Journal of American College of Cardiology...

TCT 2018: Orsiro continues to have lower rates of target lesion...

Two-year data from the BIOFLOW-V randomised trial—which compared a sirolimus stent with a biodegradable polymer (Orsiro, Biotronik) with a everoliums-eluting stent with a permanent...

TCT 2018: One-year real-world results show Portico TAVI system reduces severe...

According to one-year results from the PORTICO I study, which were presented during a late-breaking session at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting...

TCT 2018: Longest-term data to date for CoreValve study show excellent...

New data presented at 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 September, San Diego, USA), according to a press release, patients implanted with the...

TCT 2018: Use of Impella in cardiogenic shock patients associated with...

A new analysis of data from the Impella (Abiomed) Quality (IQ) Database shows a relative increase of 24% in mean survival in acute myocardial...

TCT 2018: LEADERS FREE II confirm favourable results for BioFreedom

The primary endpoint results of the LEADERS FREE II trial were presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 September, San Diego,...

TCT 2018: Restore drug-coated balloon matches Resolute for small vessel lesions

Data presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 September, San Diego, USA) indicates that the performance of Restore (Cardionovum) matches that...

TCT 2018: FFRangio may provide a faster and easier approach to...

The FAST-FFR trial, which was presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 September, San Diego, USA) and published in Circulation, indicate...

TCT 2018: Audience claps as COAPT shows MitraClip reduces HF hospitalisations

Delegates at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21-25 September, San Diego, USA) broke into spontaneous applause after Gregg Stone (Columbia University Medical...

TCT 2018: Lower rate of stent thrombosis with Resolute Onyx vs....

Data presented yesterday at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21-25 September, San Diego, USA) indicate that there were no significant differences in...

TCT 2018: Infraredx to present results of the LRP study

Results from the highly anticipated LRP (Lipid-Rich Plaque) study will be presented during a late-breaking clinical trial session at the 2018 Transcatheter Cardiovascular Therapeutics...

TCT 2018: Corindus to feature the CorPath GRX system at...

Corindus Vascular Robotics is to feature its CorPath GRX system at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 September, San Diego, USA). The...

Twenty thousand patients have now been treated with RenalGuard therapy

RenalGuard Solutions has announced the treatment of 20,000 patients with RenalGuard for the prevention of contrast-induced nephropathy. A press release reports that the system,...

Juan F Granada

Juan F Granada (president and CEO, Cardiovascular Research Foundation, New York, USA) wanted to be a physician from a young age and fell in love...